Raydiant Oximetry Secures $1 Million Grant to Advance Fetal Monitoring Technology

SAN RAMON, CA, UNITED STATES, September 24, 2024 /EINPresswire.com/ -- Raydiant Oximetry, Inc., a clinical-stage medical device company developing innovations to keep mothers and babies safe during childbirth, has announced the receipt of a $1 million grant from the Bill & Melinda Gates Foundation. The grant will support the development of Raydiant’s Lumerah™ technology, a non-invasive fetal pulse oximeter designed to enhance the detection of fetal distress during childbirth.